GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
163 hedge funds and large institutions have $1.62B invested in GenMark Diagnostics, Inc in 2021 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 29 increasing their positions, 58 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
+14
Holders Change %
+9.4%
% of All Funds
2.87%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
62
Increased
29
Reduced
58
Closed
47
Calls
$4.51M
Puts
$3.11M
Net Calls
+$1.39M
Net Calls Change
+$2.46M
Top Buyers
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$104M |
| 2 |
JPMorgan Chase & Co
New York
|
+$71.4M |
| 3 |
VI
Versor Investments
New York
|
+$63.7M |
| 4 |
TAL
TIG Advisors LLC
New York
|
+$42.4M |
| 5 |
Millennium Management
New York
|
+$41.9M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$255M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$65.4M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$40.4M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$38.1M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$32.6M |
